{"slideshow_credits": null, "snippet": "Cavan M. Redmond, a senior executive at Pfizer, will become the chief executive of WebMD, which is under pressure to bolster its share price.", "abstract": "Cavan M. Redmond, a senior executive at Pfizer, will become the chief executive of WebMD, which is under pressure to bolster its share price.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"lastname": "DE LA MERCED", "rank": 1, "firstname": "Michael", "role": "reported", "organization": "", "middlename": "J."}], "original": "By MICHAEL J. DE LA MERCED"}, "web_url": "http://dealbook.nytimes.com/2012/06/01/pfizer-executive-to-take-the-helm-of-webmd/", "lead_paragraph": null, "headline": {"main": "Pfizer Executive to Take the Helm of WebMD", "print_headline": "Pfizer Executive to Take the Helm of WebMD", "kicker": "DealBook"}, "_id": "4fd3a4878eb7c8105d8ef384", "word_count": "406", "multimedia": [], "pub_date": "2012-06-01T00:01:07Z", "source": "The New York Times", "news_desk": null, "keywords": [{"name": "organizations", "value": "Pfizer Inc", "rank": "1"}, {"name": "organizations", "value": "WebMD Health Corporation", "rank": "2"}, {"name": "subject", "value": "Appointments and Executive Changes", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}